ApicHope(SZ:300723) Zhong Zheng Wang·2025-12-22 12:28Group 1 - The controlling shareholder Guangrun Group will transfer its 9.07% stake in Arthrosi Therapeutics, Inc. to the company without any conditions, supporting the company's research and innovation development [1][2] - Arthrosi is set to be acquired by Sobi US Holding Corp. for a total of $9.5 billion upfront and up to $5.5 billion in milestone payments, with Guangrun Health's shares also being sold in the transaction [1] - The company expects this support from Guangrun Group to improve cash flow, enhance asset liquidity, and assist in the development of more innovative drug products, aligning with the long-term interests of the company and its shareholders [2] Group 2 - The company announced its first share buyback plan, intending to use between 100 million and 200 million RMB to repurchase its A-shares to maintain company value and shareholder rights [3] - On December 15, the company initiated the buyback, purchasing 706,000 shares at an average price of 32.75 RMB per share, totaling approximately 23.12 million RMB [3]